Transatlantique Private Wealth’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$283K Hold
857
0.09% 192
2025
Q3
$296K Sell
857
-152
-15% -$46K 0.1% 196
2025
Q2
$315K Sell
1,009
-1,798
-64% -$687K 0.12% 185
2025
Q1
$1.47M Buy
2,807
+144
+5% +$73.6K 0.59% 46
2024
Q4
$1.35M Sell
2,663
-754
-22% -$428K 0.51% 57
2024
Q3
$2M Buy
3,417
+823
+32% +$465K 0.76% 30
2024
Q2
$1.29M Buy
2,594
+234
+10% +$115K 0.53% 52
2024
Q1
$1.17M Sell
2,360
-19
-0.8% -$9.66K 0.51% 62
2023
Q4
$1.25M Sell
2,379
-295
-11% -$157K 0.58% 50
2023
Q3
$1.35M Buy
2,674
+5
+0.2% +$2.46K 0.72% 35
2023
Q2
$1.28M Buy
2,669
+71
+3% +$34.7K 0.67% 38
2023
Q1
$1.23M Buy
2,598
+244
+10% +$118K 0.68% 39
2022
Q4
$1.25M Buy
2,354
+30
+1% +$15.9K 0.75% 35
2022
Q3
$1.18M Buy
2,324
+719
+45% +$378K 0.79% 35
2022
Q2
$824K Buy
+1,605
New +$806K 0.57% 59

Other funds holding UNH

Transatlantique Private Wealth's UNH Position: Q4 2025 in Review

Transatlantique Private Wealth held its UnitedHealth (UNH) position steady in Q4 2025 at 857 shares worth $283K. The position accounts for 0.09% of the portfolio, ranked #192.

Transatlantique Private Wealth first reported a position in UNH in Q2 2022 and has held it in 15 quarters since. The position peaked at $2M in Q3 2024. 3,296 funds tracked by Wall St. Rank hold UNH as of Q4 2025.

  • Transatlantique Private Wealth held 857 shares of UnitedHealth worth $283K as of Q4 2025.
  • Transatlantique Private Wealth left its UnitedHealth share count unchanged in Q4 2025.
  • UnitedHealth made up 0.09% of Transatlantique Private Wealth's portfolio in Q4 2025, its #192 holding.
  • Transatlantique Private Wealth first reported a position in UnitedHealth in Q2 2022 and has held it in 15 quarters since.
  • Transatlantique Private Wealth's UnitedHealth position peaked at $2M in Q3 2024.
  • 3,296 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.